CAMBRIDGE, Mass. and LONDON, Nov. 28, 2023 ~ Flagship Pioneering, the bioplatform innovation company, today marked the official launch of its UK presence with an event co-hosted in partnership with the UK Government's Office for Life Sciences. The event brought together top leaders from industry, government, and academia to focus on breakthrough innovation and marked Flagship's public announcement of its strategic commitment to the UK life sciences ecosystem.

The move was driven by the country's strong commitment to scientific research and development, as well as its regulatory environment that supports a culture of innovation. Flagship has established an office in London, its first such office outside the United States. The new office will serve as a regional hub for Flagship's operations in the UK and into Europe.

Noubar Afeyan, Founder and CEO of Flagship Pioneering said: "We are pleased to officially debut the UK effort today, which has been expanding behind the scenes for over a year. With our announced regional hubs in both London and Singapore, Flagship aims to strengthen its position as a global leader in the biotech industry and enhance its ability to engage stakeholders around the world."

More on Boston Chron

• Powering the AI, Defense and Aerospace Future with Energy Infrastructure and Digital Asset Strength: KULR Technology Group, Inc. $KULR
• $10 Price Target in Think Equity Report Supported by Inventory Financing Floorplan Boot to $60 Million for 2026 Sales Growth in Pre-Owned Boats: $OTH
• Poolvillas Expands Local Presence on the Costa Blanca with New Offices in Moraira and Denia – Over 30 Years of Expertise Now Even Closer to Guests
• Radarsign Redefines Crosswalk Safety with Launch of CrossCommand™ RRFB Crosswalk
• OpenSSL Corporation Opens 2026 Advisory Committees' Elections: Shape the Future!

Earlier this month, Flagship announced its expansion into the Asia-Pacific region with the establishment of a hub in Singapore and appointment of André Andonian as Chair of Asia Pacific and Senior Advisor. The company creates and builds platform companies designed to generate multiple products that secure a healthier and more sustainable future. For more than 20 years, Flagship has originated and fostered more than 100 scientific ventures resulting in more than $90 billion (USD) in aggregate value. The current Flagship ecosystem comprises 40 impactful companies spanning human therapeutics, agriculture, and nutrition.

Last week's unveiling of Quotient Therapeutics marks its first company co-anchored in both Cambridge MA (US) and Cambridge (UK). Quotient's platform was created by Flagship scientists in partnership with leading geneticists at the Wellcome Sanger Institute (UK) and University of Texas Southwestern (US).

Michelle Donelan, Secretary of State for Science Innovation & Technology said: "From Brunel's engineering revolution in 19th century through to breakthroughs in genetic medicine 21st century British ideas have changed world because willingness ask big questions do things differently but be successful our innovators risk-takers need backing." She added that "Flagship Pioneering choosing UK home Europe another vote confidence mission put real financial firepower behind world-leading science backing brightest ideas serious capital help deliver improved healthcare new medical treatments high-skill jobs."

More on Boston Chron

• Boston: Mayor Michelle Wu Announces Voting Stage of Participatory Budgeting Initiative, "Ideas In Action"
• City of Boston Celebrates Completion of Flat 9 at Whittier
• Steve Everett Jr. Named President of L.T. Hampel Corporation
• Acuvance Acquires ROI Healthcare Solutions, Building a Dedicated Healthcare ERP Practice
• Max Tucci Award-Winning Media Powerhouse Launches New Podcast —Executive Produced by Emmy-Winning Daytime Icons Suzanne Bass & Fran Brescia Coniglio

Tom Kibasi Senior Vice President & UK Initiative Lead said: "The UK offers immense opportunities collaboration academic institutions research centers national data resources biotech startups we look forward continuing work closely biotech community contributing advancement scientific research development country."

Professor Lord Darzi who chairs Preemptive Health & Medicine initiative added: "The official debut Flagship UK strong growing team London comes time when biotech sector experiencing tremendous growth innovation no doubt make tremendous contribution vibrant innovative biotech ecosystem United Kingdom—benefit too."

---

Show All News | Report Violation